Purchase of bit.bio iPS-derived hepatocytes spanning multiple conditions.
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Sep 06, 2023 08:58 am EDT
- Original Date Offers Due: Sep 08, 2023 05:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Sep 23, 2023
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
- NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
- Place of Performance: Durham , NC 27709USA
Description
NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT
INTENDED SOURCE: bit.bio LTD
DESCRIPTION OF REQUIREMENT:
This contract action is for the acquisition of Laboratory Equipment from bit.bio LTD for the ioHeptocytes for which the Government intends to solicit and negotiate with only one source under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b) – Soliciting from a Single Source. The National Institute of Environmental Health Sciences (NIEHS), Office of Acquisitions (OA) intends to award a sole source purchase order to, bit.bio, Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3FH, United Kingdom. The agency is seeking a Made in America Procurement Waiver for this procurement.
- This requirement is for bit.bio iPS-derived hepatocytes spanning multiple conditions.
The use of the technology allows Induced pluripotent stem cells (iPSC) hold the promise to enable generation of any cell type from any human donor for a wide array of applications in biomedical research.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 334516 and a size standard of 750 Employees.
NIEHS will solicit and negotiate directly with bit.bio and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, if an interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities must be submitted in writing and must contain material in sufficient detail to allow the Government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. All interested parties must express their interest and capabilities in writing via email to Brian D. Moyer at moyerbr@niehs.nih.gov within three (3) days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within three (3) days, an award will be made to bit.bio LTD.
Attachments/Links
Contact Information
Contracting Office Address
- Post Office Box 12233
- Research Triangle Park , NC 27709
- USA
Primary Point of Contact
- Brian D. Moyer
- moyerbr@niehs.nih.gov
- Phone Number 9842873046